A dissolution test for a pressure-controlled colon delivery capsule: Rotating beads method

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 9, 1999, Pages 979-989

  Yoshikawa, Yukako ^a   Hu, Zhaopeng ^a   Kimura, Go ^a   Murakami, Masahiro ^a   Yoshikawa, Hiroshi ^b   Takada, Kanji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; FLUORESCEIN; MESALAZINE; PARACETAMOL; POLYVINYL ALCOHOL; TEGAFUR;

ARTICLE; COLON; DISSOLUTION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; ENTERIC COATED TABLET; MODEL; SUSTAINED RELEASE PREPARATION; VISCOSITY;

ADMINISTRATION, RECTAL; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; HUMANS; TABLETS;

EID: 0032851780     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991773447     Document Type: Article

References (29)

1. Aoki, S., Uesugi, K., Ozawa, H., Kayano, M. (1992) Evaluation of the correlation between in vivo and in vitro release of phenylpropanolamine HCl from controlled-release tablets. Int. J. Pharm. 85: 65-73
2. Ashford, M., Fell, J. T. (1994) Targeting drugs to the colon: delivery systems for oral administration. J. Drug Target. 2: 241-258
3. Ashford, M., Fell, J. T., Attwood, D., Woodhead, P. P. (1993) An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting. Int. J. Pharm. 91: 241-245
4. Digenis, G. A., Sandefer, E. (1991) Gamma scintigraphy and neutron activation techniques in the in vivo assessment of orally administered dosage forms. Crit. Rev. Ther. Drug Carrier Sys. 7: 309-345
5. El-Arini, S. K., Shiu, G. K., Skelly, J. P. (1990) Theophylline-controlled release preparations and fatty food: in vitro study using the rotating dialysis cell method. Pharm. Res. 7: 1134-1140
6. Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., Hardcastle, J. D. (1986) Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 16: 185-187
7. Gazzaniga, A., Iamartino, P., Maffione, G., Sangalli, M. E. (1994) Oral delayed-release systems for colonic specific delivery. Int. J. Pharm. 108: 77-83
8. Gazzaniga, A., Busetti, C., Moro, L., Sangalli, M. E., Giordano, F. (1995) Time-dependent oral delivery systems for colon targeting. S.T.P. Pharm. Sci. 5: 83-88
9. Gibaldi, M., Perrier, D. (1982) Pharmacokinetics. 2nd edn, Dekker, New York
10. Hardy, J. G., Davis, S. S., Wilson, C. G. (eds) (1989) Drug Delivery to the Gastrointestinal Tract. John Wiley, Chichester
11. Industrial Pharmacists Group (1991) Drugs and the gastrointestinal tract. Pharmaceut. J. 247: 137-139
12. Komuro, T., Yokota, C., Kimura, T. (1991) In-vitro dissolution properties of indomethacin extended-release capsules. J. Pharm. Pharmacol. 43: 79-82
13. Lui, C. Y., Amidon, G. L., Berardi, R. R., Fieisher, D., Youngberg, C., Dressman, J. B. (1986) Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans. J. Pharm. Sci. 75: 271-274
14. Möse, A. J. (1993) Gastroretentive dosage forms. Crit. Rev. Ther. Drug Carrier Sys. 10: 143-195
15. Murata, S., Ueda, S., Shimojo, F., Tokunaga, Y., Hata, T., Ohnishi, N. (1998) In vivo performance of time-controlled explosion system (TES) in GI physiology regulated dogs. Int. J. Pharm. 161: 161-168
16. Narisawa, S., Nagata, M., Ito, T., Yoshino, H., Hirakawa, Y., Noda, K. (1995) Drug release behavior in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled or time-controlled release preparations coated with insoluble polymer-based film. J. Contr. Rel. 33: 253-260
17. Olsson, B., Wagner, Z. G., Månsson, P., Ragnarsson, G. (1995) A gamma scintigraphic study of the absorption of morphine from controlled-release tablet. Int. J. Pharm. 119: 223-229
18. Ritschel, W. A. (1991) Targeting in the gastrointestinal tract: new approaches. Methods Find. Exp. Clin. Pharmacol. 13: 313-336
19. Röhm Pharm (1995) Information Sheets. Eudragit polymethacrylate for pharmaceutical applications.
20. Rubinstein, A., Tirosh, B., Baluom, M., Nassar, T., David, A., Radai, R., Gliko-Kabir, I., Friedman, M. (1997) The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. J. Contr. Rel. 46: 59-73
21. Saffran, M., Kumar, G. S., Savariar, C., Burnham, J. C., William, F., Neckevs, D. C. (1986) A new approach to the oral administration of insulin and other peptide drugs. Science 233: 1081-1084
22. Sako, K., Mizumoto, T., Kajiyama, A., Ohmura, T. (1996) Influence of physical factors in gastrointestinal tract on acetaminophen release from controlled-release tablets in fasted dogs. Int. J. Pharm. 137: 225-232
23. Sayani, A. P., Chein, Y. W. (1996) Systemic delivery of peptides and proteins across absorptive mucosae. Crit. Rev. Ther. Drug Carrier Syst. 13: 85-184
24. Shin-Etsu Chemical (1998) Information Sheets. Shin-Etsu POVAL (polyvinyl alcohol) for pharmaceutical applications.
25. Takaya, T., Ikeda, C., Imagawa, N., Niwa, K., Takada, K. (1995) Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CFS) in beagle dogs. J. Pharm. Pharmacol. 47: 474-478
26. Takaya, T., Sawada, K., Suzuki, H., Funaoka, A., Matsuda, K. Takada, K. (1997) Application of colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs. J. Drug Target. 4: 271-276
27. Takaya, T., Niwa, K., Muraoka, M., Ogita, I., Nagai, N., Yano, R., Kimura, G., Yoshikawa, Y., Yoshikawa, H., Takada, K. (1998) Importance of dissolution process on systemic availability of drugs delivered by colon delivery system. J. Contr. Rel. 50: 111-122
28. Wakerly, Z., Fell, J., Attwood, D., Parkins, D. (1997) Studies on admidated pectins as potential carriers in colonic drug delivery. J. Pharm. Pharmacol. 49: 622-625
29. Zahirul, M., Khan, I. (1996) Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: challenges and opportunities. Int. J. Pharm. 140: 131-143